A Look at Tandem Diabetes Care Inc (TNDM) Shares in the Recent Past Indicates Growth

With 1.1 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.92 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $45.15 whereas the lowest price it dropped to was $43.89. The 52-week range on TNDM shows that it touched its highest point at $47.00 and its lowest point at $13.82 during that stretch. It currently has a 1-year price target of $45.20. Beta for the stock currently stands at 1.22.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TNDM was up-trending over the past week, with a rise of 0.99%, but this was up by 31.13% over a month. Three-month performance surged to 83.12% while six-month performance rose 199.66%. The stock gained 36.17% in the past year, while it has gained 48.51% so far this year. A look at the trailing 12-month EPS for TNDM yields -2.17 with Next year EPS estimates of -1.09. For the next quarter, that number is -0.54. This implies an EPS growth rate of 51.64% for this year and 34.11% for next year.

Float and Shares Shorts:

At present, 65.55 million TNDM shares are outstanding with a float of 64.15 million shares on hand for trading. On 2024-04-30, short shares totaled 8.02 million, which was 1241.0 higher than short shares on 1711584000. In addition to Mr. John F. Sheridan as the firm’s President, CEO & Director, Ms. Leigh A. Vosseller serves as its Executive VP, CFO & Treasurer.

Institutional Ownership:

Through their ownership of 1.15759 of TNDM’s outstanding shares, institutional investors have minority control over the company.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-03-31, TNDM reported revenue of $191674000.0 and operating income of -$41678000.0. The EBITDA in the recently reported quarter was -$33073000.0 and diluted EPS was -$0.65.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TNDM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.